Japanese firms see innovation, emerging markets as keys to growth

07/10/2013 | BioSpectrum Asia

Japanese pharmaceutical and life science companies, facing domestic constraints on growth and profits, need to focus on innovation and expanding into emerging markets such as China and India, according to statements by leading industry officials at concurrent meetings of in-Pharma Japan and Interphex Japan in Tokyo. MSD President Tony Alvarez stressed the need to tie innovation to the customer, and Fumiyoshi Sakai of Credit Suisse Securities, Japan, urged companies to invest in markets where economic growth is substantially higher than health care expenditures.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN